大流行性流感疫苗——面临的挑战。
Pandemic influenza vaccines - the challenges.
机构信息
Myrdalskogen 95, N-5117 Ulset, Norway.
出版信息
Viruses. 2009 Dec;1(3):1089-109. doi: 10.3390/v1031089. Epub 2009 Dec 3.
Abstract
Recent years' enzootic spread of highly pathogenic H5N1 virus among poultry and the many lethal zoonoses in its wake has stimulated basic and applied pandemic vaccine research. The quest for an efficacious, affordable and timely accessible pandemic vaccine has been high on the agenda. When a variant H1N1 strain of swine origin emerged as a pandemic virus, it surprised many, as this subtype is well-known to man as a seasonal virus. This review will cover some difficult vaccine questions, such as the immunological challenges, the new production platforms, and the limited supply and global equity issues.
摘要
近年来，高致病性 H5N1 病毒在家禽中的地方性流行以及随之而来的许多致死性人畜共患病刺激了基础和应用大流行疫苗研究。寻求一种有效、经济实惠且及时可及的大流行疫苗一直是重中之重。当一种源自猪的新型 H1N1 变异株成为大流行病毒时，许多人感到惊讶，因为这种亚型是人所熟知的季节性病毒。本综述将涵盖一些困难的疫苗问题，例如免疫挑战、新的生产平台以及有限的供应和全球公平问题。
相似文献
1
Pandemic influenza vaccines - the challenges.大流行性流感疫苗——面临的挑战。
Viruses. 2009 Dec;1(3):1089-109. doi: 10.3390/v1031089. Epub 2009 Dec 3.
2
Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.接种表达神经氨酸酶的重组副流感病毒5可抵御同源和异源流感病毒攻击。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01579-17. Print 2017 Dec 1.
3
Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.通用流感病毒神经氨酸酶疫苗可诱导针对人季节性和大流行前流感株的保护性免疫应答。
J Virol. 2021 Aug 10;95(17):e0075921. doi: 10.1128/JVI.00759-21.
4
M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.新型活流感疫苗M2SR可保护小鼠和雪貂免受高致病性禽流感的侵害。
Vaccine. 2017 Jul 24;35(33):4177-4183. doi: 10.1016/j.vaccine.2017.06.039. Epub 2017 Jun 28.
5
The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets.2009 年大流行的 H1N1 病毒诱导产生的抗神经氨酸酶（NA）抗体可与雪貂体内的 H5N1 病毒的 NA 发生交叉反应。
Vaccine. 2012 Mar 28;30(15):2516-22. doi: 10.1016/j.vaccine.2012.01.090. Epub 2012 Feb 11.
6
Multi-Influenza HA Subtype Protection of Ferrets Vaccinated with an N1 COBRA-Based Neuraminidase.基于 N1 COBRA 的神经氨酸酶的流感病毒 HA 亚型多价保护作用：雪貂疫苗接种研究
Viruses. 2023 Jan 9;15(1):184. doi: 10.3390/v15010184.
7
A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.一种 VLP 疫苗可诱导针对 H5N1 和 H1N1 亚型流感病毒的广谱交叉保护抗体免疫。
PLoS One. 2012;7(8):e42363. doi: 10.1371/journal.pone.0042363. Epub 2012 Aug 7.
8
Epidemiology, ecology and gene pool of influenza A virus in Egypt: will Egypt be the epicentre of the next influenza pandemic?埃及甲型流感病毒的流行病学、生态学与基因库：埃及会成为下一次流感大流行的中心吗？
Virulence. 2015;6(1):6-18. doi: 10.4161/21505594.2014.992662.
9
An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus.基于 H5N1 M2e 的多种抗原肽疫苗可提供针对大流行 2009 年 H1N1 病毒致死感染的异型保护。
Virol J. 2010 Jul 12;7:151. doi: 10.1186/1743-422X-7-151.
10
Detection and Characterization of Swine Origin Influenza A(H1N1) Pandemic 2009 Viruses in Humans following Zoonotic Transmission.人类经动物传播感染的猪源 2009 年甲型 H1N1 流感病毒的检测与特征分析。
J Virol. 2020 Dec 22;95(2). doi: 10.1128/JVI.01066-20.
引用本文的文献
1
Microarray Gene Expression Dataset Re-analysis Reveals Variability in Influenza Infection and Vaccination.微阵列基因表达数据集再分析揭示了流感感染和疫苗接种的变异性。
Front Immunol. 2019 Nov 7;10:2616. doi: 10.3389/fimmu.2019.02616. eCollection 2019.
2
A systematic review and meta-analysis of cross-reactivity of antibodies induced by H7 influenza vaccine.H7流感疫苗诱导产生的抗体交叉反应性的系统评价与荟萃分析
Hum Vaccin Immunother. 2020;16(2):286-294. doi: 10.1080/21645515.2019.1649551. Epub 2019 Aug 23.
3
Comparative effectiveness of H7N9 vaccines in healthy individuals.在健康个体中 H7N9 疫苗的比较效果。
Hum Vaccin Immunother. 2019;15(1):80-90. doi: 10.1080/21645515.2018.1515454. Epub 2018 Sep 14.
4
Controlling epidemics with transmissible vaccines.用可传播疫苗控制传染病。
PLoS One. 2018 May 10;13(5):e0196978. doi: 10.1371/journal.pone.0196978. eCollection 2018.
5
Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice.用展示流感血凝素1（HA1）的非重组乳酸乳球菌进行口服免疫可诱导小鼠产生黏膜免疫。
PLoS One. 2017 Nov 6;12(11):e0187718. doi: 10.1371/journal.pone.0187718. eCollection 2017.
6
Equalizing access to pandemic influenza vaccines through optimal allocation to public health distribution points.通过优化向公共卫生分发点的分配来实现大流行性流感疫苗的公平获取。
PLoS One. 2017 Aug 30;12(8):e0182720. doi: 10.1371/journal.pone.0182720. eCollection 2017.
7
Available influenza vaccines: immunization strategies, history and new tools for fighting the disease.现有的流感疫苗：免疫策略、历史及对抗该疾病的新工具。
J Prev Med Hyg. 2016;57(1):E41-6.
8
Pretreatment of mice with oligonucleotide prop5 protects them from influenza virus infections.寡核苷酸 prop5 预处理可保护小鼠免受流感病毒感染。
Viruses. 2014 Feb 6;6(2):573-81. doi: 10.3390/v6020573.
9
Influenza Virus-like Particle Containing Two Different Subtypes of Hemagglutinin Confers Protection in Mice Against Lethal Challenge With A/PR8 (H1N1) and A/HK (H3N2) Viruses.含有两种不同亚型血凝素的流感病毒样颗粒可使小鼠对A/PR8（H1N1）和A/HK（H3N2）病毒的致死性攻击产生保护作用。
Iran Red Crescent Med J. 2013 Jan;15(1):75-82. doi: 10.5812/ircmj.6252. Epub 2013 Jan 5.
10
Advances and future challenges in recombinant adenoviral vectored H5N1 influenza vaccines.重组腺病毒载体 H5N1 流感疫苗的进展和未来挑战。
Viruses. 2012 Nov 1;4(11):2711-35. doi: 10.3390/v4112711.
本文引用的文献
1
Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population.一般人群中针对猪源 H1N1 流感病毒的预先存在的免疫性。
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20365-70. doi: 10.1073/pnas.0911580106. Epub 2009 Nov 16.
2
Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.2008 - 2009年三价流感疫苗对2009年甲型H1N1大流行性流感的有效性 - 美国，2009年5 - 6月
MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1241-5.
3
A novel influenza A (H1N1) vaccine in various age groups.在不同年龄组中使用新型甲型 H1N1 流感疫苗。
N Engl J Med. 2009 Dec 17;361(25):2414-23. doi: 10.1056/NEJMoa0908535. Epub 2009 Oct 21.
4
Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City.2009年甲型H1N1大流行性流感季节性三价灭活疫苗的部分保护作用：墨西哥城的病例对照研究
BMJ. 2009 Oct 6;339:b3928. doi: 10.1136/bmj.b3928.
5
Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice.肌肉内基质-M 佐剂的 H5N1 病毒样颗粒疫苗在小鼠中诱导高频率的多功能 Th1 CD4+细胞和强烈的抗体反应。
Vaccine. 2009 Dec 9;27(52):7367-76. doi: 10.1016/j.vaccine.2009.09.044. Epub 2009 Sep 23.
6
Response to a monovalent 2009 influenza A (H1N1) vaccine.对单价 2009 流感 A（H1N1）疫苗的反应。
N Engl J Med. 2009 Dec 17;361(25):2405-13. doi: 10.1056/NEJMoa0907413. Epub 2009 Sep 10.
7
Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.2009 年甲型 H1N1 流感单价 MF59 佐剂疫苗试验。
N Engl J Med. 2009 Dec 17;361(25):2424-35. doi: 10.1056/NEJMoa0907650. Epub 2009 Sep 10.
8
Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.对2009年甲型H1N1流感大流行病毒的交叉反应性抗体应答。
N Engl J Med. 2009 Nov 12;361(20):1945-52. doi: 10.1056/NEJMoa0906453. Epub 2009 Sep 10.
9
Dating the emergence of pandemic influenza viruses.确定大流行性流感病毒的出现时间。
Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11709-12. doi: 10.1073/pnas.0904991106. Epub 2009 Jul 13.
10
Historical perspective--Emergence of influenza A (H1N1) viruses.历史视角——甲型H1N1流感病毒的出现
N Engl J Med. 2009 Jul 16;361(3):279-85. doi: 10.1056/NEJMra0904322. Epub 2009 Jun 29.
Zotero 插件